Efficacy and Tolerability of a New Facial 2-Mercaptonicotinoyl Glycine-Containing Depigmenting Serum Versus Hydroquinone 4% over 3-Month Treatment of Facial Melasma
Abstract Introduction Topical treatment with hydroquinone 4% and hydroquinone-based preparations is the gold standard of care for melasma; however, it is limited by complications. 2-Mercaptonicotinoyl glycine (Melasyl™) is a new active ingredient targeting melanin synthesis without impairing the tyr...
Saved in:
| Main Authors: | Thierry Passeron, Delphine Kerob, Guénaëlle Le Dantec, Anne-Laure Demessant-Flavigny, Alessandro R. do Nascimento, Renato Moura, Samir Salah, Mariana Feiges, Erika Fernandez, Andrew Alexis |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Adis, Springer Healthcare
2025-06-01
|
| Series: | Dermatology and Therapy |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/s13555-025-01473-4 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluating the efficacy of Terminalia chebula Retz. 5% cream compared to hydroquinone 2% cream in the treatment of melasma
by: Amir Emad Kheirieh, et al.
Published: (2024-09-01) -
Efficacy of topical Raphanus sativus seed powder mixed with honey versus hydroquinone 4 % cream in the treatment of melasma – A randomized controlled trial
by: Arshan Horti, et al.
Published: (2024-12-01) -
A novel UPLC – PDA method for simultaneous determination of hydroquinone, oxybenzone and octinoxate: An in-vitro study
by: Ram Kumar Gummaluri, et al.
Published: (2023-07-01) -
Usage Frequency and Ecotoxicity of Skin Depigmenting Agents
by: Sandra Mota, et al.
Published: (2025-03-01) -
Relationship Between Facial Melasma and Ocular Photoaging Diseases
by: Lunla Udomwech, et al.
Published: (2025-05-01)